Clinical Trials on HER2 Positive Solid Tumor in Ireland
Total 155 results
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
Cancer Trials IrelandCompletedBreast Cancer | HER2 Positive Breast Cancer | HER2 Negative Breast CancerIreland
-
TYK Medicines, IncRecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States
-
Institute of Cancer Research, United KingdomNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited Kingdom
-
Puma Biotechnology, Inc.TerminatedSolid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsFrance, United States, Spain, Belgium, United Kingdom, Serbia, Australia, Israel, Canada, Denmark, Ireland, Italy, Korea, Republic of
-
Daiichi SankyoRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States, Japan
-
Cancer Trials IrelandRecruitingHER2-positive Breast CancerIreland
-
Cancer Trials IrelandTerminatedHER2-positive Breast Cancer | TNM Stage II-IV Breast CancerIreland, Italy
-
Children's Cancer and Leukaemia GroupUnknownUnspecified Childhood Solid Tumor, Protocol SpecificIreland, United Kingdom
-
Cancer Trials IrelandTerminated
-
Children's Cancer and Leukaemia GroupUnknownUnspecified Childhood Solid Tumor, Protocol SpecificIreland, United Kingdom
-
Cancer Trials IrelandActive, not recruitingSolid Tumor Spine MetastasesIreland
-
Pyxis Oncology, IncRecruiting
-
Cancer Trials IrelandCompletedHER2 Positive Breast CancerIreland
-
Butler HospitalNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Brown UniversityNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Brown UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Aadi Bioscience, Inc.RecruitingMalignant Solid Neoplasm | Neoplasms | Cancer | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Metastasis | Advanced Solid Tumor | Metastatic Solid Tumor | Advanced Cancer | Tumor | Malignant Neoplasm | Malignant Tumor | Tumors | Cancer Metastatic | Tumor, Solid | Malignant Solid Tumor | TSC | TSC1 | TSC2 | Metastatic NeoplasmKorea, Republic of, United States, Puerto Rico
-
Daiichi SankyoCompletedHER2-positive Breast CancerSpain, Ireland, Italy
-
MiNK TherapeuticsCompletedTumor, SolidUnited States
-
Agenus Inc.Active, not recruiting
-
Eli Lilly and CompanyCompletedCancer | Solid TumorUnited States
-
SanofiRecruitingSolid TumorUnited States, Israel, Netherlands, Spain
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Eli Lilly and CompanyRecruitingRelapsed Solid Tumor | Refractory Solid TumorUnited States, Canada, Australia, Belgium, France, Spain, Germany, Italy
-
Children's Cancer and Leukaemia GroupCompletedSarcoma | Unspecified Childhood Solid Tumor, Protocol Specific | Brain and Central Nervous System TumorsUnited Kingdom, Ireland
-
Repare TherapeuticsRoche Pharma AGActive, not recruitingAdvanced Solid TumorUnited States, Canada, Denmark, United Kingdom
-
Roger Williams Medical CenterTerminatedNeoplasms | Metastatic Cancer | Solid Tumors | TumorsUnited States
-
Repare TherapeuticsDebiopharm International SARecruitingAdvanced Solid TumorUnited States, Canada, Denmark
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Australia
-
Cancer Trials IrelandCompletedUnspecified Adult Solid Tumor, Protocol Specific | Spinal Cord CompressionIreland
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone... and other conditionsUnited States
-
Ningbo Newbay Technology Development Co., LtdRecruitingAdvanced Solid TumorUnited States, China, Korea, Republic of, Spain, France, United Kingdom
-
MedImmune LLCCompletedCancer | Solid TumorsUnited States, Spain
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
Cancer Trials IrelandCompletedPain | Unspecified Adult Solid Tumor, Protocol Specific | Radiation Toxicity | Spinal Cord CompressionIreland
-
Chugai PharmaceuticalCompletedSolid TumorsUnited States, France, Netherlands
-
AstraZenecaQuintiles, Inc.CompletedSolid TumorsUnited States, France, United Kingdom, Netherlands
-
Helsinki University Central HospitalTampere University HospitalEnrolling by invitationSolid TumorDenmark, Norway, Sweden, Finland, Netherlands, Iceland, Ireland
-
Hoffmann-La RocheRecruitingAdvanced Solid TumorsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Australia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
MedImmune LLCCompletedA Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid TumorsAdvanced Solid TumorsUnited States, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Boston Children's HospitalCompletedSarcoma | Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Neuroblastoma | Central Nervous System Tumor, PediatricUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingUnresectable Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Metastatic Breast Adenocarcinoma | Metastatic HER2-Positive Breast Carcinoma | Recurrent Breast Adenocarcinoma | Recurrent HER2-Positive Breast Carcinoma | Unresectable HER2-Positive Breast CarcinomaUnited States, Canada
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more